These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21425983)

  • 1. Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier.
    Stenehjem DD; Hartz AM; Bauer B; Anderson GW
    Future Med Chem; 2009 Dec; 1(9):1623-41. PubMed ID: 21425983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
    Löscher W; Potschka H
    Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Various drug delivery approaches to the central nervous system.
    Pasha S; Gupta K
    Expert Opin Drug Deliv; 2010 Jan; 7(1):113-35. PubMed ID: 20017662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The blood-brain barrier and drug delivery in the central nervous system].
    Loch-Neckel G; Koepp J
    Rev Neurol; 2010 Aug; 51(3):165-74. PubMed ID: 20645267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel central nervous system drug delivery systems.
    Stockwell J; Abdi N; Lu X; Maheshwari O; Taghibiglou C
    Chem Biol Drug Des; 2014 May; 83(5):507-20. PubMed ID: 24325540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blood-brain barrier and cancer: transporters, treatment, and Trojan horses.
    Deeken JF; Löscher W
    Clin Cancer Res; 2007 Mar; 13(6):1663-74. PubMed ID: 17363519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling of blood-brain barrier nutrient transporters: in silico basis for evaluation of potential drug delivery to the central nervous system.
    Allen DD; Geldenhuys WJ
    Life Sci; 2006 Feb; 78(10):1029-33. PubMed ID: 16126231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug delivery to the central nervous system: a review.
    Misra A; Ganesh S; Shahiwala A; Shah SP
    J Pharm Pharm Sci; 2003; 6(2):252-73. PubMed ID: 12935438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain.
    Pardridge WM
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):683-91. PubMed ID: 14579518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier.
    Reichel A; Begley DJ; Abbott NJ
    J Cereb Blood Flow Metab; 2000 Jan; 20(1):168-74. PubMed ID: 10616805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CNS efflux drug transporters in antiepileptic drug delivery: overcoming CNS efflux drug transport.
    Potschka H
    Adv Drug Deliv Rev; 2012 Jul; 64(10):943-52. PubMed ID: 22210135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of peptides to the brain: emphasis on therapeutic development.
    Banks WA
    Biopolymers; 2008; 90(5):589-94. PubMed ID: 18335425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L
    Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential receptor-mediated drug targeting to the diseased brain.
    Rip J; Schenk GJ; de Boer AG
    Expert Opin Drug Deliv; 2009 Mar; 6(3):227-37. PubMed ID: 19327042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?
    Sanchez-Covarrubias L; Slosky LM; Thompson BJ; Davis TP; Ronaldson PT
    Curr Pharm Des; 2014; 20(10):1422-49. PubMed ID: 23789948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of membrane transporters in drug delivery to brain tumors.
    Nies AT
    Cancer Lett; 2007 Aug; 254(1):11-29. PubMed ID: 17275180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the brain--surmounting or bypassing the blood-brain barrier.
    Potschka H
    Handb Exp Pharmacol; 2010; (197):411-31. PubMed ID: 20217538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane transporter/receptor-targeted prodrug design: strategies for human and veterinary drug development.
    Majumdar S; Duvvuri S; Mitra AK
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1437-52. PubMed ID: 15191791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.